In the second study – the UK Breast Screening Frequency trial – researchers randomized nearly 100,000 women to either an annual or a three – yearly mammogram after the date of the first screening to which they her 50th Have been invited birthday. In a previous paper , the researchers had predicted, that annual screening would not result in a further reduction in breast cancer mortality over the three-year interval standard in the UK http://clomidhelp.com . The actual mortality rates confirm today that this is the case.
Mr. Jacques Fracheboud, a senior researcher at the Erasmus Medical Center , and colleagues found that was by 2003, after screening after screening for women aged 70-75, there were a steady decline in deaths from breast cancer among women aged 75-79. Until 2006, breast cancer mortality was 29.5 percent lower than the average for the period 1986-1997 for this age group – a time when breast cancer mortality in women aged 75-79 remained stable. In 1986-1997 the average deaths per 100,000 deaths per 100,000 women aged 75-79 and in 2006 it was 117 per 100th It will take several years before a significant effect of the control can be seen, therefore breast cancer mortality was analyzed at age 75.
, we found a key mechanism to control Neural Stem Cell developing.